Health & Biotech
Health Check: Aussie biotechs avoid DEFCON-1 alert amid tariff war – but it’s no time to be off guard
Road to 2025: Clever Culture Systems advancing APAS Independence
Arovella tackles CAR-T’s limitations in cancer treatment with off-the-shelf innovation
Health Check: Telix edges closer to a radiotherapy for difficult brain cancers
Biocurious: Compumedics uses noodle to become a leader in global brain and sleep diagnosis sectors
Argent and AusCann partner to accelerate cannabinoid pharma development
Health Check: Trump says a pharma tax is in the offing – with no negotiation
Dr Boreham’s Crucible: Drug-development unicorn Neuren banks on ‘cascade of long-term growth’
Health Check: With the FDA’s approval, EBR is ready to revolutionise the heart failure device market
Why sheep could hold the key to next-gen healing tech, as Aroa herds in first profit
Scott Power: ASX health stocks fall in roller coaster week; Monash falls on embryo mix-up
Health Kick Podcast: How Arovella is bringing hope with off-the-shelf cell therapy
Recce raising up to $15.8m for Phase III trials
Orthocell gains Brazil regulatory approval for dental regeneration product Striate+
Health Check: Yippee! Biotechs join broader rally after Trump tariff turnaround
EZZ boosts retail presence with new pharmacy deal
Health Kick Podcast: Deep dive into AdAlta’s East to West strategy
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
